{"transactions":[{"id":2327797,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":129011,"kind":"person","name":"Sundar Padmavathi","position":1,"cik":"0001778709","reported_name":"Sundar Padmavathi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:24:05.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":87500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001493152-22-007201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778709/000149315222007201/ownership.xml","form_type":"4"}},{"id":2327796,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":129011,"kind":"person","name":"Sundar Padmavathi","position":1,"cik":"0001778709","reported_name":"Sundar Padmavathi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:24:05.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":87500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001493152-22-007201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778709/000149315222007201/ownership.xml","form_type":"4"}},{"id":2826827,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":129011,"kind":"person","name":"Sundar Padmavathi","position":1,"cik":"0001778709","reported_name":"Sundar Padmavathi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-01T16:35:04.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":255000,"price":5.34,"value":1361700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to her continued service as an employee on the applicable vesting date."}],"balance_after":255000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0001493152-21-005107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778709/000149315221005107/ownership.xml","form_type":"4"}},{"id":2944612,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":129011,"kind":"person","name":"Sundar Padmavathi","position":1,"cik":"0001778709","reported_name":"Sundar Padmavathi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing & Market Access"}}],"security":"Common Stock","published_at":"2020-12-15T06:25:27.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":4177,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":4177,"source":{"system":"sec-edgar","filing":"0001493152-20-023595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778709/000149315220023595/ownership.xml","form_type":"4"}},{"id":3277285,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":129011,"kind":"person","name":"Sundar Padmavathi","position":1,"cik":"0001778709","reported_name":"Sundar Padma","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Marketing & Market Access"}}],"security":"Option to purchase common stock","published_at":"2020-02-12T21:52:30.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":255000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on February 10, 2020 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date.(1)"}],"balance_after":255000,"derivative":{"exercise_price":2.63,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0001493152-20-002153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778709/000149315220002153/ownership.xml","form_type":"4"}}]}